BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26850628)

  • 1. Cardiac CT assessment of left ventricular mass in mid-diastasis and its prognostic value.
    Klein R; Ametepe ES; Yam Y; Dwivedi G; Chow BJ
    Eur Heart J Cardiovasc Imaging; 2017 Jan; 18(1):95-102. PubMed ID: 26850628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful MACE risk stratification in hypertrophic cardiomyopathy patients using different 2D speckle-tracking TTE approaches.
    Ozawa K; Funabashi N; Takaoka H; Kobayashi Y
    Int J Cardiol; 2017 Feb; 228():1015-1021. PubMed ID: 27931009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Implications of LV Strain Risk Score in Asymptomatic Patients With Hypertensive Heart Disease.
    Saito M; Khan F; Stoklosa T; Iannaccone A; Negishi K; Marwick TH
    JACC Cardiovasc Imaging; 2016 Aug; 9(8):911-21. PubMed ID: 27344417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vectors through a cross-sectional image (VCI): A visualization method for four-dimensional motion analysis for cardiac computed tomography.
    Kidoh M; Utsunomiya D; Funama Y; Ashikaga H; Nakaura T; Oda S; Yuki H; Hirata K; Iyama Y; Nagayama Y; Fukui T; Yamashita Y; Taguchi K
    J Cardiovasc Comput Tomogr; 2017 Nov; 11(6):468-473. PubMed ID: 28967574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of late gadolinium enhancement quantification in cardiac magnetic resonance imaging of hypertrophic cardiomyopathy with systolic dysfunction.
    Funada A; Kanzaki H; Noguchi T; Morita Y; Sugano Y; Ohara T; Hasegawa T; Hashimura H; Ishibashi-Ueda H; Kitakaze M; Yasuda S; Ogawa H; Anzai T
    Heart Vessels; 2016 May; 31(5):758-70. PubMed ID: 25820658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strong cardiovascular prognostic implication of quantitative left atrial contractile function assessed by cardiac magnetic resonance imaging in patients with chronic hypertension.
    Kaminski M; Steel K; Jerosch-Herold M; Khin M; Tsang S; Hauser T; Kwong RY
    J Cardiovasc Magn Reson; 2011 Aug; 13(1):42. PubMed ID: 21843343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left Ventricular Dilatation Increases the Risk of Ventricular Arrhythmias in Patients With Reduced Systolic Function.
    Aleong RG; Mulvahill MJ; Halder I; Carlson NE; Singh M; Bloom HL; Dudley SC; Ellinor PT; Shalaby A; Weiss R; Gutmann R; Sauer WH; Narayanan K; Chugh SS; Saba S; London B
    J Am Heart Assoc; 2015 Jul; 4(8):e001566. PubMed ID: 26231842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.
    Nucifora G; Muser D; Gianfagna P; Morocutti G; Proclemer A
    Int J Cardiovasc Imaging; 2015 Dec; 31(8):1603-10. PubMed ID: 26210792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of myocardial deformation with cardiac magnetic resonance strain imaging improves risk stratification in patients with dilated cardiomyopathy.
    Buss SJ; Breuninger K; Lehrke S; Voss A; Galuschky C; Lossnitzer D; Andre F; Ehlermann P; Franke J; Taeger T; Frankenstein L; Steen H; Meder B; Giannitsis E; Katus HA; Korosoglou G
    Eur Heart J Cardiovasc Imaging; 2015 Mar; 16(3):307-15. PubMed ID: 25246506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LV Mass Independently Predicts Mortality and Need for Future Revascularization in Patients Undergoing Diagnostic Coronary Angiography.
    Abdi-Ali A; Miller RJH; Southern D; Zhang M; Mikami Y; Knudtson M; Heydari B; Howarth AG; Lydell CP; James MT; Wilton SB; White JA
    JACC Cardiovasc Imaging; 2018 Mar; 11(3):423-433. PubMed ID: 28734928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Right ventricular hypertrophy is associated with cardiovascular events in hypertrophic cardiomyopathy: evidence from study with magnetic resonance imaging.
    Nagata Y; Konno T; Fujino N; Hodatsu A; Nomura A; Hayashi K; Nakamura H; Kawashiri MA; Yamagishi M
    Can J Cardiol; 2015 Jun; 31(6):702-8. PubMed ID: 25935883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproducibility of left and right ventricular mass measurements with cardiac CT.
    Schwarz F; Takx R; Schoepf UJ; Lee YS; Ruzsics B; Gassner EM; Chiaramida S; Henzler T
    J Cardiovasc Comput Tomogr; 2011; 5(5):317-24. PubMed ID: 21875827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of left ventricular global function index in patients after ST-segment elevation myocardial infarction.
    Reinstadler SJ; Klug G; Feistritzer HJ; Kofler M; Pernter B; Göbel G; Henninger B; Müller S; Franz WM; Metzler B
    Eur Heart J Cardiovasc Imaging; 2016 Feb; 17(2):169-76. PubMed ID: 26056134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of computed tomography-derived left ventricular size with major cardiovascular events in the general population: the Heinz Nixdorf recall study.
    Dykun I; Geisel MH; Kälsch H; Lehmann N; Bauer M; Moebus S; Jöckel KH; Möhlenkamp S; Erbel R; Mahabadi AA
    Atherosclerosis; 2015 May; 240(1):46-52. PubMed ID: 25746377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spirito-Maron echocardiographic score: a marker for morphological and physiological assessment of patients with hypertrophic cardiomyopathy.
    Rangel I; Gonçalves A; de Sousa C; Correia AS; Pinho T; Madureira AJ; Martins E; Cardoso JS; Macedo F; Maciel MJ
    Echocardiography; 2014 Jul; 31(6):708-15. PubMed ID: 24460546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of extensive LV remodeling limits the benefits of CRT in patients with intraventricular dyssynchrony.
    Carluccio E; Biagioli P; Alunni G; Murrone A; Pantano P; Biscottini E; Zuchi C; Zingarini G; Cavallini C; Ambrosio G
    JACC Cardiovasc Imaging; 2011 Oct; 4(10):1067-76. PubMed ID: 21999865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Combined Incremental Prognostic Value of LVEF, Late Gadolinium Enhancement, and Global Circumferential Strain Assessed by CMR.
    Mordi I; Bezerra H; Carrick D; Tzemos N
    JACC Cardiovasc Imaging; 2015 May; 8(5):540-549. PubMed ID: 25890580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of cardiac power output to left ventricular mass in patients with left ventricular dysfunction and dobutamine stress echo negative by wall motion criteria.
    Cortigiani L; Sorbo S; Miccoli M; Scali MC; Simioniuc A; Morrone D; Bovenzi F; Marzilli M; Dini FL
    Eur Heart J Cardiovasc Imaging; 2017 Feb; 18(2):153-158. PubMed ID: 27129537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Assessment of global and regional left ventricular function with a 16-slice spiral-CT using two different software tools for quantitative functional analysis and qualitative evaluation of wall motion changes in comparison with magnetic resonance imaging].
    Koch K; Oellig F; Kunz P; Bender P; Oberholzer K; Mildenberger P; Hake U; Kreitner KF; Thelen M
    Rofo; 2004 Dec; 176(12):1786-93. PubMed ID: 15573290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left atrial passive emptying function during dobutamine stress MR imaging is a predictor of cardiac events in patients with suspected myocardial ischemia.
    Farzaneh-Far A; Ariyarajah V; Shenoy C; Dorval JF; Kaminski M; Curillova Z; Wu H; Brown KB; Kwong RY
    JACC Cardiovasc Imaging; 2011 Apr; 4(4):378-88. PubMed ID: 21492813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.